FINALLY! Real Hope for Alzheimer's Patients! Jeffrey Madden, a BioTech CEO

Jeffrey Madden is a Co-founder and Chief Executive Officer at ADvantage Therapeutics, which is a clinical biotechnology firm developing a novel immunotherapy for Alzheimer’s Disease. His career spans more than 20 years in the investment management industry including Partner and Portfolio Manager at IronBridge Capital Management and Senior Vice President and Portfolio Manager at RMB Capital. He also worked at Accenture in the Retail Management Consulting Practice. Jeffrey is an active board member and lead investor of Rational Vaccines, which is developing therapeutic and prophylactic live attenuated vaccines for HSV-1 and HSV-2. He also serves on the boards of Leading India’s Future Today, which offers educational programs attuned to sound economic thinking; and the Bartley J. Madden Foundation, which creates employment opportunities for those most in need. Jeffrey graduated from the University of Iowa with Business Honors and Distinction.